Searched for
DAIICHI SANKYO BRASIL FARMACEUTICA LTDA
Tokyo Court to rule on Fortis arm IHH and Daiichi Sankyo disputeA significant legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. The Tokyo District Court will announce its jud...
IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...
Despite litigation, IHH says it is focused on key milestones for FortisMalaysia-based hospital operator IHH Healthcare has reached out to its largest shareholder Mitsui & Co. to help open communication with Jap...
Petrobras clears offshore project with BPCL in BrazilState-run BPCL announced that the SEAP-I project in Brazil, operated by Petrobras, has received Final Investment Decision. BPCL, through it...
Daiichi comments continue to damage interests: IHH UnitNorthern TK Venture, a subsidiary of IHH Healthcare, has increased its legal claim against Daiichi Sankyo. The claim is now for ₹11,800 cro...
Fortis Open Offer: Daiichi Sankyo's 'misleading' statements continue to damage interests, says NTKIHH Healthcare's subsidiary, NTK, accuses Daiichi Sankyo of damaging its interests through misleading statements regarding the Fortis Healt...
Kalpataru Power Transmission arm acquires 51% stake in FasttelEarlier in February KPTL had informed BSE the indicative time period for closing of the acquisition of Fasttel Engenharia, a Brazilian EPC ...
Ranbaxy, Daiichi Sankyo to collaborate in Brazil to expand businessIn Brazil, Daiichi Sankyo has built up its market presence with innovative pharmaceuticals through Daiichi Sankyo Brazil.
- Daiichi Sankyo and Ranbaxy Launch hybrid business in Venezuela
Daiichi Sankyo & Ranbaxy announced that Daiichi Sankyo Venezuela would begin marketing Ranbaxy products in Venezuela as part of hybrid busi...
- Ranbaxy to sell Daiichi Sankyo product in Malaysia
Drug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo today said Ranbaxy will market its parent company's products in Malaysia.
- Ranbaxy Laboratories to sell Daiichi Sankyo's products in Italy
Ranbaxy Laboratories and its parent firm Daiichi Sankyo said they have entered into a partnership to distribute the Japanese firm's product...
- Ranbaxy, Daiichi Sankyo to expand business in Mexico
The two cos will launch Daiichi Sankyo's Olmesartan Medoxomil, used to treat high blood pressure, in Mexico before end of 2011.
- Daiichi to use Ranbaxy network to sell products in Singapore
Ranbaxy and Daiichi Sankyo had signed a three-year plan to exploit synergies in operations to enhance their generic as well as branded busi...
- Ranbaxy transfers new drug discovery unit to Daiichi Sankyo
Ranbaxy Laboratories on Friday said it has transferred its new drug discovery research unit (NDDR) to Daiichi Sankyo India Pharma.
- Daiichi to meet FDA, launches 1st drug through Ranbaxy
Daiichi Sankyo, the new owner of Ranbaxy Laboratories will meet US Food and Drugs Administration (FDA) officials next month to sort out the...
- Daiichi Sankyo defers open offer to acquire Zenotech Labs
Daiichi Sankyo has deferred the open offer to acquire 20% from public shareholders of Zenotech Labs as it is yet to get the approval from I...
- Zydus buys Nikkho of Brazil for $25 m
In its second overseas acquisition this year, Ahmedabad-based Rs 1,800-crore Zydus Cadila has picked up 100% stake in Quimica e Farmaceutic...